Highlights of the 11th International Workshop on Waldenstrom's Macroglobulinemia: What we learned, and how it will impact scientific discovery and patient care
- PMID: 37202255
- DOI: 10.1053/j.seminhematol.2023.05.001
Highlights of the 11th International Workshop on Waldenstrom's Macroglobulinemia: What we learned, and how it will impact scientific discovery and patient care
Conflict of interest statement
Declaration of Competing Interest RGS declares honoraria from Amgen, Takeda, Janssen, Incyte, Astellas, BeiGene, AstraZeneca, Pfizer; and research funding from Novartis, Gilead, Astellas, Janssen; and participation in advisory boards for Amgen, Pharmacyclics, Takeda. JSM declares participation on advisory boards and consulting services, on behalf of my Institution, for Abbvie, Amgen, BMS, Celgene, GSK, Haemalogix, Janssen-Cilag, Karyopharm, MSD, Novartis, Pfizer, Takeda, Regeneron, Roche, Sanofi, and SecuraBio. SPT received research funding, and/or consulting fees from Abbvie/Pharmacyclics Inc, Janssen Oncology Inc, Beigene Inc, Eli Lilly Pharmaceuticals, and Bristol Myers Squibb. CJP has no disclosures.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources